KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31

Pasithea Therapeutics Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.41−0.01 (-1.83%)

Close on Oct 19, 2026

Market cap: $13.23M
P/E (TTM): –
Dividend yield: –

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Pasithea Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Pasithea Therapeutics filed with the SEC

May 4, 2026, 5:00 PM ET
PRESS RELEASE DATED MAY 4, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Dec 2, 2025, 9:23 AM ET
PRESS RELEASE, DATED NOVEMBER 28, 2025, ANNOUNCING THE PRICING OF THE OFFERING
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Dec 2, 2025, 9:23 AM ET
PRESS RELEASE, DATED DECEMBER 2, 2025, ANNOUNCING THE CLOSING OF THE OFFERING
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.2 to Form 8-K
Nov 25, 2025, 4:15 PM ET
PRESS RELEASE DATED NOVEMBER 20, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Nov 25, 2025, 4:15 PM ET
PRESS RELEASE DATED NOVEMBER 21, 2025
Regulation FD disclosure · Other events · EX-99.2 to Form 8-K
Nov 25, 2025, 4:15 PM ET
PRESS RELEASE DATED NOVEMBER 24, 2025
Regulation FD disclosure · Other events · EX-99.3 to Form 8-K
Nov 4, 2025, 7:04 AM ET
PRESS RELEASE DATED NOVEMBER 4, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Sep 16, 2025, 7:04 AM ET
PRESS RELEASE DATED SEPTEMBER 16, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
May 7, 2025, 5:18 PM ET
PRESS RELEASE, DATED MAY 6, 2025, ANNOUNCING THE PRICING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
May 7, 2025, 5:18 PM ET
PRESS RELEASE, DATED MAY 7, 2025, ANNOUNCING THE CLOSING OF THE OFFERING
Material agreement · Regulation FD disclosure · EX-99.2 to Form 8-K
Sep 30, 2024, 4:49 PM ET
PRESS RELEASE, DATED SEPTEMBER 26, 2024
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Sep 26, 2024, 8:45 AM ET
PRESS RELEASE DATED SEPTEMBER 26, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Sep 14, 2023, 9:11 AM ET
PRESS RELEASE OF PASITHEA THERAPEUTICS CORP. ISSUED SEPTEMBER 14, 2023
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Jul 20, 2023, 8:56 AM ET
PRESS RELEASE OF PASITHEA THERAPEUTICS CORP. ISSUED JULY 20, 2023
Other events · EX-99.1 to Form 8-K
Dec 14, 2022, 5:02 PM ET
PRESS RELEASE DATED DECEMBER 12, 2022
Material agreement · Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
Oct 12, 2022, 9:15 AM ET
PRESS RELEASE DATED OCTOBER 12, 2022
Material agreement · Acquisition or disposition completed · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Jun 22, 2022, 4:15 PM ET
PRESS RELEASE DATED JUNE 22, 2022
Material agreement · Acquisition or disposition completed · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Nov 29, 2021, 5:26 PM ET
PRESS RELEASE ISSUED NOVEMBER 24, 2021
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K